Dr. H G. Nagendra
Dr. H G. Nagendra obtained his Ph.D degree from IISc, India on Molecular Biophysics and M.Sc in Physics (Spectroscopy) from Bangalore university. He has 14 years of experience and expertise in computational biology to appreciate and analyze the micro-array data from specific sources towards identification of novel gene products as potential markers and facilitate the Development of PCR-based kits to Detect KCNMA1 alternative splice variants and associated genes for Diagnosis of Breast Cancer Metastasis. He has 23 research publications. Since 2005, he is working in Sir M Visvesvaraya Institute of Technology Bangalore as professor and Head.
Dr. Laxmi Reddy, PhD, DABCC is a promoter, director & Chief Scientific Officer of SBM Pvt. Ltd. He is also the Director, Molecular Diagnostic Laboratories, University of Chicago, Medical Center, Chicago, USA. He is internationally recognized expert in the field of Molecular Diagnostics, with more than 25 years of experience in the diagnostic laboratory business, specializing in clinical and molecular diagnostic laboratories. He received his Ph.D. in Clinical Neurochemistry from NIMHANS, Bangalore, India, 1990, and had professional experience in the University of Chicago Medical Center, Technical Director, 2004-present, Chicago, IL. Molecular Diagnostics lab, Rush Cancer Institute, Chicago, IL. In addition Dr. Reddy is Board Certified in Molecular Diagnostics by American Association of Clinical Chemistry. His novel research include: Detection of the reverse transcriptase activity (retroviruses) in bone marrow culture supernatants of Myelodysplastic Syndromes (Patented), Development of molecular diagnostic assays for detection of mutations in alpha and beta globin genes (Patented). He has authored over 40 scientific publications and presented in over 100 international scientific meetings.
Dr. Thimappa Hegde, MS. a renowned neurosurgeon, directing the Neurosurgery Institute at Narayana Hridyalaya, Bangalore, India will serve as medical consultant for SBM’s clinical diagnostic operations. Dr. Hegde will assist in identifying clinical trial facilities and make sue these facilities meet FDA and an ICH guideline, and specially meets the GCP (good clinical facility) standards.
Dr. Divya Khaitan
Dr. Giridhar Babu